Overview

Study in Patients With COPD

Status:
Completed

Trial end date:
2005-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine which dose of the investigational drug is the most safe and effective for the treatment of COPD compared to the control drug

Phase:

Phase 2

Details

Lead Sponsor:

Dey

Treatments:

Formoterol Fumarate